iRhythm Technologies International

iRhythm Technologies International is a digital‑health company that transforms cardiac arrhythmia diagnosis through a wearable biosensing platform combined with cloud‑based analytics and machine‑learning. Its flagship product, ZIO, delivers first‑line ambulatory electrocardiogram (ECG) monitoring for patients at risk of arrhythmias, enabling physicians to identify and treat irregular heart rhythms more rapidly and accurately than traditional methods. By reducing indeterminate tests and facilitating timely medical intervention, iRhythm helps prevent downstream complications such as stroke, positioning itself as a leading provider of innovative cardiac monitoring solutions.